Roger Song
Stock Analyst at Jefferies
(0.69)
# 3,734
Out of 4,783 analysts
43
Total ratings
25%
Success rate
-23.87%
Average return
Main Sectors:
Stocks Rated by Roger Song
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SANA Sana Biotechnology | Initiates: Buy | $7 | $1.85 | +279.40% | 1 | Mar 14, 2025 | |
| KRYS Krystal Biotech | Initiates: Buy | $245 | $182.75 | +34.06% | 1 | Mar 5, 2025 | |
| WVE Wave Life Sciences | Initiates: Buy | $26 | $9.01 | +188.57% | 1 | Feb 25, 2025 | |
| IGMS IGM Biosciences | Downgrades: Hold | $48 → $2 | $1.28 | +56.25% | 2 | Jan 10, 2025 | |
| BIOA BioAge Labs | Downgrades: Hold | $42 → $7 | $3.88 | +80.41% | 2 | Dec 9, 2024 | |
| REPL Replimune Group | Maintains: Buy | $16 → $19 | $10.45 | +81.82% | 1 | Dec 4, 2024 | |
| KURA Kura Oncology | Maintains: Buy | $32 → $28 | $7.14 | +292.16% | 2 | Nov 21, 2024 | |
| ACRS Aclaris Therapeutics | Upgrades: Buy | $2 → $7 | $1.62 | +332.10% | 1 | Nov 19, 2024 | |
| IRON Disc Medicine | Initiates: Buy | $89 | $52.47 | +69.62% | 1 | Oct 23, 2024 | |
| NVAX Novavax | Maintains: Buy | $31 → $25 | $7.26 | +244.35% | 2 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $41 | $12.55 | +226.69% | 1 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $8.03 | +335.87% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $23.36 | +71.23% | 1 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $3.26 | +176.07% | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $129 | $70.77 | +82.28% | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2.5 → $8 | $0.62 | +1,197.44% | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $97 | $73.62 | +31.76% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $72 | $16.73 | +330.36% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $110 | $26.13 | +320.97% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $0.5 → $1 | $0.76 | +31.96% | 10 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $35 | $5.57 | +528.37% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.68 | +1,220.04% | 1 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $3.37 | +137.39% | 2 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $0.24 | +1,537.33% | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $0.74 | +2,737.84% | 1 | Sep 2, 2020 |
Sana Biotechnology
Mar 14, 2025
Initiates: Buy
Price Target: $7
Current: $1.85
Upside: +279.40%
Krystal Biotech
Mar 5, 2025
Initiates: Buy
Price Target: $245
Current: $182.75
Upside: +34.06%
Wave Life Sciences
Feb 25, 2025
Initiates: Buy
Price Target: $26
Current: $9.01
Upside: +188.57%
IGM Biosciences
Jan 10, 2025
Downgrades: Hold
Price Target: $48 → $2
Current: $1.28
Upside: +56.25%
BioAge Labs
Dec 9, 2024
Downgrades: Hold
Price Target: $42 → $7
Current: $3.88
Upside: +80.41%
Replimune Group
Dec 4, 2024
Maintains: Buy
Price Target: $16 → $19
Current: $10.45
Upside: +81.82%
Kura Oncology
Nov 21, 2024
Maintains: Buy
Price Target: $32 → $28
Current: $7.14
Upside: +292.16%
Aclaris Therapeutics
Nov 19, 2024
Upgrades: Buy
Price Target: $2 → $7
Current: $1.62
Upside: +332.10%
Disc Medicine
Oct 23, 2024
Initiates: Buy
Price Target: $89
Current: $52.47
Upside: +69.62%
Novavax
Oct 16, 2024
Maintains: Buy
Price Target: $31 → $25
Current: $7.26
Upside: +244.35%
Oct 11, 2024
Initiates: Buy
Price Target: $41
Current: $12.55
Upside: +226.69%
Oct 8, 2024
Initiates: Buy
Price Target: $35
Current: $8.03
Upside: +335.87%
Sep 13, 2024
Initiates: Buy
Price Target: $40
Current: $23.36
Upside: +71.23%
Sep 5, 2024
Initiates: Buy
Price Target: $9
Current: $3.26
Upside: +176.07%
Sep 3, 2024
Maintains: Buy
Price Target: $108 → $129
Current: $70.77
Upside: +82.28%
May 6, 2024
Upgrades: Buy
Price Target: $2.5 → $8
Current: $0.62
Upside: +1,197.44%
Apr 17, 2024
Initiates: Buy
Price Target: $97
Current: $73.62
Upside: +31.76%
Mar 20, 2024
Maintains: Buy
Price Target: $41 → $72
Current: $16.73
Upside: +330.36%
Mar 7, 2024
Initiates: Buy
Price Target: $110
Current: $26.13
Upside: +320.97%
Mar 6, 2024
Maintains: Hold
Price Target: $0.5 → $1
Current: $0.76
Upside: +31.96%
Aug 31, 2022
Maintains: Buy
Price Target: $30 → $35
Current: $5.57
Upside: +528.37%
Jul 29, 2022
Initiates: Buy
Price Target: $9
Current: $0.68
Upside: +1,220.04%
Dec 1, 2021
Initiates: Buy
Price Target: $8
Current: $3.37
Upside: +137.39%
Nov 12, 2021
Upgrades: Buy
Price Target: $3 → $4
Current: $0.24
Upside: +1,537.33%
Sep 2, 2020
Initiates: Buy
Price Target: $21
Current: $0.74
Upside: +2,737.84%